 Connection
Katrina Claw to Pharmacogenetics
This is a "connection" page, showing publications Katrina Claw has written about Pharmacogenetics.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.006 |
|
|
|
-
Claw KG, Dorr CR, Woodahl EL. Implementing community-engaged pharmacogenomics in Indigenous communities. Nat Commun. 2024 Jan 31; 15(1):920.
Score: 0.786
-
Claw KG, Beans JA, Lee SB, Avey JP, Stapleton PA, Scherer SE, El-Boraie A, Tyndale RF, Nickerson DA, Dillard DA, Thummel KE, Robinson RF. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations. Nicotine Tob Res. 2020 May 26; 22(6):910-918.
Score: 0.609
-
Wichman ML, Wall DM, Garcia Mota SS, Killam SR, Brown KE, Aagaard K, Swaney J, Muzquiz LI, Corum BN, Claw KG, Woodahl EL. Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community. Clin Transl Sci. 2025 Mar; 18(3):e70194.
Score: 0.212
-
Sherman CA, Claw KG, Lee SB. Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences. Sci Rep. 2024 10 01; 14(1):22774.
Score: 0.206
-
Wroblewski TH, Witt KE, Lee SB, Malhi RS, Peede D, Huerta-S?nchez E, Villanea FA, Claw KG. Pharmacogenetic Variation in Neanderthals and Denisovans and Implications for Human Health and Response to Medications. Genome Biol Evol. 2023 12 01; 15(12).
Score: 0.194
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|